AnalystsRobyn Karnauskas
Robyn Karnauskas's Stock Forecasts

Analyst Ranking
Bottom 16%
#4167 out of 4929 analysts
Average Return
-0.25%
Win Rate
39%57 out of 146
Risk vs Reward
Poor
Good

Robyn Karnauskas's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Bioxcel Therapeutics IncBTAI
+1,137.30%$71.20$880.96
2019-11-12 -
2020-11-12
Strong Buy
Rayzebio IncRYZB
+212.45%$20.00$62.49
2023-10-10 -
2024-02-23
Strong Buy
Immunovant IncIMVT
+192.80%$16.94$49.60
2020-01-10 -
2021-01-08
Strong Buy
Absci CorpABSI
+158.75%$1.60$4.14
2023-08-16 -
2024-08-15
Strong Buy
Kodiak Sciences IncKOD
+116.19%$69.35$149.93
2020-02-06 -
2021-02-05
Strong Buy

Robyn Karnauskas's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Abcellera Biologics IncABCL
2Strong Buy$10.00+163.16%Maintains
2 months ago
Amgen IncAMGN
9Hold$298.00-0.08%Maintains
6 months ago
Bristol Myers Squibb CoBMY
2Strong Buy$65.00+38.53%Maintains
6 months ago
Merck & Co IncMRK
11Hold$110.00+35.92%Downgrades
6 months ago
Gilead Sciences IncGILD
10Hold$83.00-25.73%Maintains
a year ago
Abbvie IncABBV
8Strong Buy$210.00+10.95%Reiterates
a year ago
Biogen IncBIIB
13Strong Buy$340.00N/AMaintains
a year ago
Curis IncCRIS
2Strong Buy$26.00N/AMaintains
a year ago
Coherus Biosciences IncCHRS
11Strong Buy$7.00N/AMaintains
a year ago
Regeneron Pharmaceuticals IncREGN
14Strong Buy$1,135.00N/AMaintains
a year ago
Biomea Fusion IncBMEA
2Strong Buy$55.00N/AReiterates
a year ago
Omniab IncOABI
2Strong Buy$10.00N/AMaintains
a year ago
Absci CorpABSI
4Strong Buy$9.00N/AMaintains
a year ago
Tourmaline Bio IncTRML
2Strong Buy$74.00N/AReiterates
a year ago
Roivant Sciences LtdROIV
5Strong Buy$23.00N/AReiterates
a year ago
Immunovant IncIMVT
5Strong Buy$48.00N/AReiterates
a year ago
Arcus Biosciences IncRCUS
5Strong Buy$50.00N/AReiterates
a year ago
Eli Lilly & CoLLY
4Strong Buy$850.00N/AReiterates
a year ago
Vertex Pharmaceuticals IncVRTX
10Strong Buy$508.00N/AMaintains
a year ago
Pfizer IncPFE
5Strong Buy$36.00N/AMaintains
2 years ago
Rayzebio IncRYZB
1Strong Buy$29.00N/AInitiates Coverage On
2 years ago
Ptc Therapeutics IncPTCT
1Hold$25.00N/ADowngrades
2 years ago
Biomarin Pharmaceutical IncBMRN
5Strong Buy$140.00N/AReiterates
2 years ago
Nucana PLCNCNA
2Strong Buy$150.00N/AReiterates
2 years ago
Fate Therapeutics IncFATE
3Hold$7.00N/AReiterates
2 years ago
Bioxcel Therapeutics IncBTAI
5Strong Buy$496.00N/AMaintains
2 years ago
Uniqure NvQURE
1Strong Buy$55.00N/AMaintains
2 years ago
Mei Pharma IncMEIP
4HoldN/AN/ADowngrades
3 years ago
Instil Bio IncTIL
2Strong Buy$320.00N/AMaintains
3 years ago
Kodiak Sciences IncKOD
3Strong Buy$15.00N/AMaintains
3 years ago
Infinity Pharmaceuticals IncINFI
2Strong Buy$4.00N/AMaintains
3 years ago
Deciphera Pharmaceuticals IncDCPH
3Hold$10.00N/ADowngrades
4 years ago
Dicerna Pharmaceuticals IncDRNA
3Hold$32.00N/ADowngrades
4 years ago
Athenex IncATNXQ
1Hold$120.00N/ADowngrades
4 years ago
Opthea LtdOPT
1Strong Buy$25.00N/AInitiates Coverage On
5 years ago
Applied Therapeutics IncAPLT
1Strong Buy$85.00N/AInitiates Coverage On
5 years ago
Celgene CorpCELG
3Hold$77.00N/AMaintains
7 years ago
Alexion Pharmaceuticals IncALXN
4Strong Buy$190.00N/AMaintains
7 years ago
Five Prime Therapeutics IncFPRX
1Strong Buy$44.00N/AMaintains
7 years ago
Acceleron Pharma IncXLRN
2Strong Buy$63.00N/AMaintains
7 years ago
Juno Therapeutics IncJUNO
1HoldN/AN/ADowngrades
7 years ago
Kite Pharma IncKITE
1Hold$87.00N/ADowngrades
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.